Andrew Regan - Director, 10%+ Owner at Conduit Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
CDT, CDTTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Regan since 9/18/2023

Holdings reported by Andrew Regan for Conduit Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Shares 45.5M Sep 22, 2023 Indirect
Common Stock, par value $0.0001 per share ("Shares") 66.7K Sep 22, 2023 Direct

There are no transactions reported by Andrew Regan for Conduit Pharmaceuticals Inc.